EnsoData, Nonin partner to increase access to home sleep testing
By HME News Staff
Updated 9:36 AM CDT, Wed August 28, 2024
MADISON, Wisc. – A new partnership will combine the EnsoSleep PPG software as a medical device (SaMD) algorithm with Nonin’s WristOx Model 3150 reusable wrist-worn device to offer sleep labs an affordable solution to test for sleep apnea at home. Nonin’s WristOx Model 3150 delivers fast, accurate oxygen saturation and pulse rate readings in challenging conditions, including low perfusion and in motion, by using sensors that provide continuous SpO2 monitoring and data recording. “Customers who choose Nonin choose durability, accuracy and equity,” said John Hastings, CEO of Nonin Medical. “Combining our class-leading noninvasive monitoring products with EnsoData’s innovative AI platform will increase patient access to quality diagnosis in the significantly under-served field of sleep apnea.” Earlier this year, EnsoData received 510(k) clearance from the U.S. Food and Drug Administration for EnsoSleep, an AI-driven analysis of PPG signals, to support the diagnosis of sleep disorders using any FDA-cleared pulse oximeter. “This partnership is an important step toward increasing patient access to quality sleep care,” said Justin Mortara, CEO of EnsoData. “As a trusted manufacturer of high-quality pulse oximetry solutions, Nonin’s devices provide more innovative hardware options for our customers to use in conjunction with EnsoSleep PPG. We are excited to launch this collaboration and continue to grow the EnsoData network of sleep medicine partnerships.” EnsoData has also partnered with React Health, Aeroflow Health and Parachute Health.
Comments